Not Found
On Demand

Chronic Pain


Total Credits: 2 including 2 AOA Category 1-A Credit(s)

Average Rating:
   4.6
State Associations:
IOMA - Iowa
Faculty:
Jolene Smith, DO |  Karry Smith, PhD, MPH
Duration:
1 Hour 57 Minutes
Expiration:
Never expires.


Description

The goal of this lecture is to understand the evolution of pain management, treatment with opioids, overdose epidemic, and currently accepted be practices for treating patients.
 
Learning Objectives:
1. This lecture will focus on the osteopathic approach to treating chronic pain.
2. Historical perspective
3. CDC guidelines
4. Unintended consequences
5. Pain management best practices
6. Common chronic pain conditions/non-opioid alternatives
7. Case studies
 
The Iowa Osteopathic Medical Association is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 2.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.  
 
Grievances Related to the Returned CME Program Administration and Evaluation Document - It is the policy of the Iowa Osteopathic Medical Association (IOMA) that all grievances related to the returned CME program administration and evaluation document will be referred to the Board of Trustees and whatever action they deem necessary will be taken.
 

Faculty

Jolene Smith, DO's Profile

Jolene Smith, DO Related seminars and products


Dr. Smith is a pain medicine physician who is board certified in both pain medicine and anesthesiology by the American Board of Anesthesiology. She holds medical licensure in Iowa and Minnesota and serves as a consultant for Boston Scientifi, Medtronic, Abbott, and Regenexx. Her professional interests include interventions such as spinal cord stimulation, intrathecal pump placement, and cannabinoids. She is firmly committed to educating students, colleagues, and the community about pain management–to this end, she successfully spearheaded an initiative at Mercy Hospital to create a lecture series about pain management. 

Dr. Smith is also an Adjunct Associate Professor at Des Moines University and has co-developed an elective course for health professions students about pain management and addiction medicine; they are currently teaching the second cohort enrolled in this course. She has been interested in cannabinoids as therapies for pain since 2015 - to that end she has earned a graduate certificate in Cannabis Medicine from Thomas Jefferson University and has plans to pursue a master’s degree in the same field.

Dr. Smith discloses that he has no relevant financial relationships with any organization producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.


Karry Smith, PhD, MPH's Profile

Karry Smith, PhD, MPH Related seminars and products


Dr. Karry Smith earned a Master of Public Health (MPH) degree and a PhD in Cell Biology from the University of Iowa. She has worked in the pharmaceutical industry since 2014 and is currently a Medical Writing Manager at Greenwich Biosciences, the company that makes the FDA-approved, cannabinoid-based product Epidiolex. In 2019, Dr. Smith earned a graduate certificate in cannabinoid pharmacology from Thomas Jefferson University in Philadelphia.


Dr. Smith has longstanding interests in pain medicine, addiction, opioids, and cannabinoids. To that end, she is currently pursuing a Doctor of Public Health (DrPH) degree at Johns Hopkins in Health Policy and Management and hopes to focus her research on pain and the safety of cannabinoids co-administered with opioids. She is passionate about education and is currently co-teaching a special topics course to healthcare students at Des Moines University that focuses on pain management and associated issues.

Dr. Smith is an employee of Greenwich Biosciences/GW Pharma.  She was previously (withing the past 12 months) a paid consultant for MedPharm Iowa, a state-licensed medical cannabis manufacturer.

Dr. Smith discloses that he has no relevant financial relationships with any organization producing, marketing, reselling or distributing health care goods or services consumed by, or used on, patients relative to the content of this presentation.

 


Please wait ...

Back to Top